Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Encephalopathy due to sulfite oxidase deficiency is a rare neurometabolic disorder characterized by seizures, progressive encephalopathy and lens dislocation.
No HPO annotations are available for this condition.
Isolated sulfite oxidase deficiency (ISOD), a rare inborn error of metabolism of sulfur-containing amino acids, comprises a spectrum ranging from classic early-onset (severe) disease to late-onset (mild) disease .
Classic ISOD typically manifests within few hours to days of life with intractable seizures, feeding difficulties, and rapidly progressive encephalopathy . The clinical features resemble that of neonatal hypoxic ischemic encephalopathy. Almost all affected infants are born after uncomplicated pregnancy. Of note, sustained abdominal trembling resembling vibration of mobile phones (interpreted as fetal seizures) has been reported in the third trimester in one instance . Delivery is usually uncomplicated, although Apgar scores may be depressed.
Classic early-onset (severe) and late-onset (mild) isolated sulfite oxidase deficiency (ISOD) should be suspected in infants with the following clinical, neuroimaging, and supportive laboratory findings.
Clinical Features
Classic ISOD
Source: GeneReviews — "Isolated Sulfite Oxidase Deficiency"
No approved treatments are currently available for encephalopathy due to sulfite oxidase deficiency. The disease remains an area of unmet medical need.
To establish the extent of disease and/or needs in an individual with a diagnosis of isolated sulfite oxidase deficiency (ISOD), the following evaluations are recommended:
Complete neurologic assessment by a pediatric neurologist
Periodic assessment by the multidisciplinary team with particular attention to the following:
Nutritional status
Neurologic status including evaluation of dosages of anti-seizure medication and their side effects
Degree of spasticity and related complications, including scoliosis
No clinical trials have been registered for encephalopathy due to sulfite oxidase deficiency.
6 publications have been identified in PubMed for encephalopathy due to sulfite oxidase deficiency. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Basic Science / Preclinical (17%).
Selvanathan A (2025). [PMID: 40121797](https://pubmed.ncbi.nlm.nih.gov/40121797/). *Molecular genetics and metabolism*. [Case Report / Case Series]
Göde L (2025). [PMID: 40440599](https://pubmed.ncbi.nlm.nih.gov/40440599/). *PloS one*. [Epidemiology / Natural History]
Ferreira EA (2024). [PMID: 39669634](https://pubmed.ncbi.nlm.nih.gov/39669634/). *Genetics in medicine open*. [Review / Meta-Analysis]
Glänzel NM (2024). [PMID: 39704910](https://pubmed.ncbi.nlm.nih.gov/39704910/). *Metabolic brain disease*. [Basic Science / Preclinical]
Schwahn BC (2024). [PMID: 38627985](https://pubmed.ncbi.nlm.nih.gov/38627985/). *Journal of inherited metabolic disease*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 4:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Source: GeneReviews — "Isolated Sulfite Oxidase Deficiency"
Table 2. Disorders to Consider in the Differential Diagnosis of Isolated Sulfite Oxidase Deficiency (ISOD)
DiffDx Disorder | Gene(s) | MOI | Features of DiffDx Disorder |
|---|---|---|---|
GPHN | AR | Intractable seizures feeding difficulties in 1st few hrs to days of life; subsequent severe ID, spasticity, seizures refractory to ASM | serum uric acid levels; urinary xanthine hypoxanthine levels due to loss of function of xanthine dehydrogenase Glycine encephalopathy |
GCSH | AR | Progressive lethargy, hypotonia, myoclonic jerks in 1st few hrs to days of life; subsequent profound ID seizures refractory to ASM | glycine levels in plasma CSF; on MRI: diffusion restriction of areas that are myelinating at birth (e.g., posterior limb of internal capsule pericentral area) Pyridoxine-dependent epilepsy |
ALDH7A1 | AR | Soon after birth: seizures refractory to ASM | Seizures respond to large supplements of pyridoxine. Pyridox(am)ine 5'-phosphate oxidase deficiency |
PNPO | AR | Soon after birth: seizures refractory to ASM pyridoxine | Seizures respond to pyridoxal-5 phosphate. ASM = anti-seizure medication; AR = autosomal recessive; DiffDx = differential diagnosis; ID = intellectual disability; MOI = mode of inheritance |
Source: GeneReviews — "Isolated Sulfite Oxidase Deficiency"
Formal developmental assessment
Ophthalmologic evaluation
EEG/video EEG to monitor seizures
Assessment of feeding and nutrition and appropriate intervention
Consultation with a clinical geneticist and/or genetic counselor
To date, no definitive treatment for ISOD has been identified. Symptomatic management by a multidisciplinary team consisting of specialists in neurology, nutrition, gastroenterology, pulmonary medicine, physiotherapy, and orthopedics is recommended. Management includes the following:
Appropriate medications for management of seizures and spasticity
Early consideration of gastrostomy tube placement to manage difficulties with swallowing to assure adequate caloric intake and reduce the risk of aspiration.
Appropriate management of vomiting, gastroesophageal reflux disease, and aspiration pneumonia
Chest physiotherapy to prevent respiratory complications
Sleep studies to assess nocturnal hypoventilation and institute appropriate interventions
Assessment for scoliosis
The following treatment modalities have been tried with minimal success:
Source: GeneReviews — "Isolated Sulfite Oxidase Deficiency"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Isolated Sulfite Oxidase Deficiency"
View trials for encephalopathy due to sulfite oxidase deficiency
Periodic sleep studies
Source: GeneReviews — "Isolated Sulfite Oxidase Deficiency"
Estimated prevalence: Unknown (Unknown prevalence).
Sayed J (2024). [PMID: 39005576](https://pubmed.ncbi.nlm.nih.gov/39005576/). *Clinical case reports*. [Case Report / Case Series]